333
Views
7
CrossRef citations to date
0
Altmetric
Review

Recent Progress in the Development of Opaganib for the Treatment of Covid-19

, , , , , & ORCID Icon show all
Pages 2199-2211 | Published online: 12 Jul 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lynn W Maines, Cecelia L Green, Staci N Keller, Leo R Fitzpatrick & Charles D Smith. (2022) The Sphingosine Kinase 2 Inhibitor Opaganib Protects Against Acute Kidney Injury in Mice. International Journal of Nephrology and Renovascular Disease 15, pages 323-334.
Read now

Articles from other publishers (6)

Sabine Kugler, Lisa Hahnefeld, Jan Andreas Kloka, Sebastian Ginzel, Elina Nürenberg-Goloub, Sebastian Zinn, Maria JGT. Vehreschild, Kai Zacharowski, Simone Lindau, Evelyn Ullrich, Jan Burmeister, Jörn Kohlhammer, Joachim Schwäble, Robert Gurke, Erika Dorochow, Alexandre Bennett, Stephanie Dauth, Julia Campe, Tilo Knape, Volker Laux, Aimo Kannt, Michaela Köhm, Gerd Geisslinger, Eduard Resch & Frank Behrens. (2024) Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units. Talanta 268, pages 125295.
Crossref
Lynn W. Maines, Staci N. Keller & Charles D. Smith. (2023) Opaganib (ABC294640) Induces Immunogenic Tumor Cell Death and Enhances Checkpoint Antibody Therapy. International Journal of Molecular Sciences 24:23, pages 16901.
Crossref
Simona Fenizia, Melania Gaggini & Cristina Vassalle. (2023) The Sphingolipid-Signaling Pathway as a Modulator of Infection by SARS-CoV-2. Current Issues in Molecular Biology 45:10, pages 7956-7973.
Crossref
Valeria J. Sarapura Martinez, Brenda Buonincontro, Chiara Cassarino, Juliana Bernatowiez, Ana Colado, Gregorio Cordini, Maria del Rosario Custidiano, Carolina Mahuad, Miguel A. Pavlovsky, Raimundo F. Bezares, Nicolás O. Favale, Mónica Vermeulen, Mercedes Borge, Mirta Giordano & Romina Gamberale. (2023) Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia. Frontiers in Oncology 13.
Crossref
Jessica Ceramella, Domenico Iacopetta, Maria Stefania Sinicropi, Inmaculada Andreu, Annaluisa Mariconda, Carmela Saturnino, Federica Giuzio, Pasquale Longo, Stefano Aquaro & Alessia Catalano. (2022) Drugs for COVID-19: An Update. Molecules 27:23, pages 8562.
Crossref
Lynn W. Maines, Randy S. Schrecengost, Yan Zhuang, Staci N. Keller, Ryan A. Smith, Cecelia L. Green & Charles D. Smith. (2022) Opaganib Protects against Radiation Toxicity: Implications for Homeland Security and Antitumor Radiotherapy. International Journal of Molecular Sciences 23:21, pages 13191.
Crossref